VKH
ABBV icon

Virtu KCG Holdings’s AbbVie ABBV Stock Holding History

Virtu KCG Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-27,800
Closed -$1.43M – 3574
2014
Q1 		$1.43M Buy
27,800
+5,400
+24% +$273K 0.02% 950
2013
Q4 		$1.18M Buy
+22,400
New +$1.1M 0.01% 1070

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's ABBV Position: Q2 2017 in Review

Virtu KCG Holdings increased its AbbVie (ABBV) stake by 249% in Q2 2017, buying an estimated $1.01M and bringing the position to 21,008 shares worth $1.52M. The position accounts for 0.04% of the portfolio, ranked #351.

Virtu KCG Holdings first reported a position in ABBV in Q3 2013 and has held it in 14 quarters since. The position peaked at $3.94M in Q1 2016. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Virtu KCG Holdings held 21,008 shares of AbbVie worth $1.52M as of Q2 2017.
  • Virtu KCG Holdings bought 14,980 AbbVie shares in Q2 2017, an estimated $1.01M.
  • AbbVie made up 0.04% of Virtu KCG Holdings's portfolio in Q2 2017, its #351 holding.
  • Virtu KCG Holdings first reported a position in AbbVie in Q3 2013 and has held it in 14 quarters since.
  • Virtu KCG Holdings's AbbVie position peaked at $3.94M in Q1 2016.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.